12 Best Scientific Instruments Stocks to Buy Right Now

Page 9 of 10

2. Thermo Fisher Scientific Inc. (NYSE:TMO)

Number of Hedge Fund Holders: 100

Thermo Fisher Scientific Inc. (NYSE:TMO) is a global leader in supporting life sciences research and improving patient health through its innovative products and services. The company provides a comprehensive portfolio across various sectors, including reagents, instruments, and consumables for biological and medical research.

In Q4 2024, the company introduced its Thermo Scientific™ iCAP™ MX Series ICP-MS, a state-of-the-art inductively coupled plasma mass spectrometry platform designed to enhance trace elemental analysis for a variety of applications in environmental, food, and industrial laboratories. This launch further cements Thermo Fisher Scientific Inc. (NYSE:TMO)’s leadership in analytical technologies, offering cutting-edge solutions to researchers across diverse fields.

For the full year 2024, Thermo Fisher Scientific Inc. (NYSE:TMO) reported stable revenue of $42.88 billion, slightly up from $42.86 billion in 2023. Despite the flat growth, the company saw a solid improvement in profitability, with GAAP diluted EPS rising to $16.53 from $15.45 in 2023, reflecting a 7% increase. Operating income also grew, reaching $7.34 billion, compared to $6.86 billion in 2023.

On February 3, 2025, Andrew Cooper of Raymond James reiterated a “Buy” rating on Thermo Fisher Scientific Inc. (NYSE:TMO) and raised the price target from $650 to $667.

Page 9 of 10